The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans

PLoS Pathogens

Volumn 3, Issue 11, 2007, Pages 1603-1616

  Morschhäuser, Joachim ^a   Barker, Katherine S ^b,c   Liu, Teresa T ^b   Blaß Warmuth, Julia ^a   Homayouni, Ramin ^d   Rogers, P David ^b,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c LE BONHEUR CHILDREN'S MEDICAL CENTER   (United States)

^d University of Memphis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CERULENIN; DIAMIDE; FLUCONAZOLE; MULTIDRUG RESISTANCE PROTEIN 1; OXIDOREDUCTASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MRR1P; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT; GLYCOPROTEIN P;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; CELL DAMAGE; FUNGAL GENE; FUNGAL VIRULENCE; FUNGUS ISOLATION; FUNGUS MUTATION; GENE EXPRESSION REGULATION; GENE ISOLATION; GENE TARGETING; HOMOZYGOSITY; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROTEIN FUNCTION; PROTEIN TRANSPORT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; BIOSYNTHESIS; DNA MICROARRAY; DRUG EFFECT; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IN SITU HYBRIDIZATION; MOLECULAR GENETICS; MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

CANDIDA ALBICANS;

ANTIFUNGAL AGENTS; BASE SEQUENCE; BLOTTING, SOUTHERN; CANDIDA ALBICANS; DRUG RESISTANCE, MULTIPLE, FUNGAL; FLOW CYTOMETRY; FLUCONAZOLE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, FUNGAL; GENES, MDR; HUMANS; IN SITU HYBRIDIZATION; MOLECULAR SEQUENCE DATA; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P-GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 37349095258     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.0030164     Document Type: Article

References (52)

1. Odds FC (1988) Candida and candidosis: a review and bibliography. London: Bailliere Tindall.
2. White TC, Marr KA, Bowden RA (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11: 382-402.
3. Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, et al. (1995) Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39: 2378-2386.
4. White TC (1997) Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 41: 1482-1487.
5. White TC (1997) The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14a demethylase in Candida albicans. Antimicrob Agents Chemother 41: 1488-1494.
6. Sanglard D, Ischer F, Koymans L, Bille J (1998) Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother 42: 241-253.
7. Lopez-Ribot JL, McAtee RK, Lee LN, Kirkpatrick WR, White TC, et al. (1998) Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother 42: 2932-2937.
8. Franz R, Kelly SL, Lamb DC, Kelly DE, Ruhnke M, et al. (1998) Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob Agents Chemother 42: 3065-3072.
9. Franz R, Ruhnke M, Morschhäuser J (1999) Molecular aspects of fluconazole resistance development in Candida albicans. Mycoses 42: 453-458.
10. Perea S, Lopez-Ribot JL, Kirkpatrick WR, McAtee RK, Santillan RA, et al. (2001) Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 45: 2676-2684.
11. Morschhäuser J (2002) The genetic basis of fluconazole resistance development in Candida albicans. Biochim Biophys Acta 1587: 240-248.
12. Fling ME, Kopf J, Tamarkin A, Gorman JA, Smith HA, et al. (1991) Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol Gen Genet 227: 318-329.
13. Prasad R, De Wergifosse P, Goffeau A, Balzi E (1995) Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet 27: 320-329.
14. Sanglard D, Ischer F, Monod M, Bille J (1996) Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 40: 2300-2305.
15. Sanglard D, Ischer F, Monod M, Bille J (1997) Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143: 405-416.
16. Gupta V, Kohli A, Krishnamurthy S, Puri N, Aalamgeer SA, et al. (1998) Identification of polymorphic mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance, and its in vitro transcriptional activation. Curr Genet 34: 192-199.
17. Staib P, Moran GP, Sullivan DJ, Coleman DC, Morschhäuser J (2001) Isogenic strain construction and gene targeting in Candida dubliniensis. J Bacteriol 183: 2859-2865.
18. Karababa M, Coste AT, Rognon B, Bille J, Sanglard D (2004) Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Antimicrob Agents Chemother 48: 3064-3079.
19. Harry JB, Oliver BG, Song JL, Silver PM, Little JT, et al. (2005) Drug-induced regulation of the MDR1 promoter in Candida albicans. Antimicrob Agents Chemother 49: 2785-2792.
20. Rognon B, Kozovska Z, Coste AT, Pardini G, Sanglard D (2006) Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance. Microbiology 152: 3701-3722.
21. Wirsching S, Michel S, Morschhäuser J (2000) Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates. Mol Microbiol 36: 856-865.
22. Wirsching S, Moran GP, Sullivan DJ, Coleman DC, Morschhäuser J (2001) MDR1-mediated drug resistance in Candida dubliniensis. Antimicrob Agents Chemother 45: 3416-3421.
23. Kusch H, Biswas K, Schwanfelder S, Engelmann S, Rogers PD, et al. (2004) A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains. Mol Genet Genomics 271: 554-565.
24. Wirsching S, Michel S, Köhler G, Morschhäuser J (2000) Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor. J Bacteriol 182: 400-404.
25. Hiller D, Stahl S, Morschhäuser J (2006) Multiple cis-acting sequences mediate upregulation of the MDR1 efflux pump in a fluconazole-resistant clinical Candida albicans isolate. Antimicrob Agents Chemother 50: 2300-2308.
26. Riggle PJ, Kumamoto CA (2006) Transcriptional regulation of MDR1, encoding a drug efflux determinant, in fluconazole-resistant Candida albicans strains through an Mcm1p binding site. Eukaryot Cell 5: 1957-1968.
27. Coste AT, Karababa M, Ischer F, Bille J, Sanglard D (2004) TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot Cell 3: 1639-1652.
28. Coste AT, Turner V, Ischer F, Morschhäuser J, Forche A, et al. (2006) A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at Chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics 172: 2139-2156.
29. Saidane S, Weber S, De Deken X, St-Germain G, Raymond M (2006) PDR16-mediated azole resistance in Candida albicans. Mol Microbiol 60: 1546-1562.
30. Reuß O, Vik Å, Kolter R, Morschhäuser J (2004) The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341: 119-127.
31. Hiller D, Sanglard D, Morschhäuser J (2006) Overexpression of the MDR1 gene is sufficient to confer increased resistance to toxic compounds in Candida albicans. Antimicrob Agents Chemother 50: 1365-1371.
32. de Micheli M, Bille J, Schueller C, Sanglard D (2002) A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol Microbiol 43: 1197-1214.
33. Morschhäuser J, Michel S, Staib P (1999) Sequential gene disruption in Candida albicans by FLP-mediated site-specific recombination. Mol Microbiol 32: 547-556.
34. Wu W, Pujol C, Lockhart SR, Soll DR (2005) Chromosome loss followed by duplication is the major mechanism of spontaneous mating-type locus homozygosis in Candida albicans. Genetics 169: 1311-1327.
35. Wu W, Lockhart SR, Pujol C, Srikantha T, Soll DR (2007) Heterozygosity of genes on the sex chromosome regulates Candida albicans virulence. Mol Microbiol 64: 1587-1604.
36. Wang Y, Cao YY, Jia XM, Cao YB, Gao PH, et al. (2006) Cap1p is involved in multiple pathways of oxidative stress response in Candida albicans. Free Radic Biol Med 40: 1201-1209.
37. Kusch H, Engelmann S, Albrecht D, Morschhäuser J, Hecker M (2007) Proteomic analysis of the oxidative stress response in Candida albicans. Proteomics 7: 686-697.
38. Jia JH, Wang Y, Cao YB, Gao PH, Jia XM, et al. (2007) CaIPF7817 is involved in the regulation of redox homeostasis in Candida albicans. Biochem Biophys Res Commun 359: 163-167.
39. Braun BR, van Het Hoog M, d'Enfert C, Martchenko M, Dungan J, et al. (2005) A human-curated annotation of the Candida albicans genome. PLoS Genet 1: e1. doi:10.1371/journal.pgen.0010001
40. Skoneczna A, Micialkiewicz A, Skoneczny M (2007) Saccharomyces cerevisiae Hsp31p, a stress response protein conferring protection against reactive oxygen species. Free Radic Biol Med 42: 1409-1420.
41. Warringer J, Blomberg A (2006) Involvement of yeast YOL151W/GRE2 in ergosterol metabolism. Yeast 23: 389-398.
42. Lucau-Danila A, Delaveau T, Lelandais G, Devaux F, Jacq C (2003) Competitive promoter occupancy by two yeast paralogous transcription factors controlling the multidrug resistance phenomenon. J Biol Chem 278: 52641-52650.
43. Banks D, Soliman MR (1997) Protective effects of antioxidants against benomyl-induced lipid peroxidation and glutathione depletion in rats. Toxicology 116: 177-181.
44. Kobayashi D, Kondo K, Uehara N, Otokozawa S, Tsuji N, et al. (2002) Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob Agents Chemother 46: 3113-3117.
45. Alarco AM, Raymond M (1999) The bZip transcription factor Cap1p is involved in multidrug resistance and oxidative stress response in Candida albicans. J Bacteriol 181: 700-708.
46. Zhang X, De Micheli M, Coleman ST, Sanglard D, Moye-Rowley WS (2000) Analysis of the oxidative stress regulation of the Candida albicans transcription factor, Cap1p. Mol Microbiol 36: 618-629.
47. Reuß O, Morschhäuser J (2006) A family of oligopeptide transporters is required for growth of Candida albicans on proteins. Mol Microbiol 60: 795-812.
48. Köhler GA, White TC, Agabian N (1997) Overexpression of a cloned IMP dehydrogenase gene of Candida albicans confers resistance to the specific inhibitor mycophenolic acid. J Bacteriol 179: 2331-2338.
49. Millon L, Manteaux A, Reboux G, Drobacheff C, Monod M, et al. (1994) Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J Clin Microbiol 32: 1115-1118.
50. Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, et al. (1994) Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol 32: 2092-2098.
51. Albert TJ, Norton J, Ott M, Richmond T, Nuwaysir K, et al. (2003) Light-directed 5′->3′ synthesis of complex oligonucleotide microarrays. Nucleic Acids Res 31: e35.
52. Schmitt ME, Brown TA, Trumpower BL (1990) A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. Nucleic Acids Res 18: 3091-3092.